Revolution Medicines Inc

Stock Chart, Company Information, and Scan Results

$107.39(as of Jan 8, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Revolution Medicines Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$107.39
Ticker SymbolRVMD
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees809
CountyUSA
Market Cap$19,855.9M
EBIDTA-1,029.8M
10-Day Moving Average84.91
P/E Ratio-21.15
20-Day Moving Average81.66
Forward P/E Ratio0.00
50-Day Moving Average73.85
Earnings per Share-5.19
200-Day Moving Average48.59
Profit Margin-Infinity%
RSI88.38
Shares Outstanding193.3M
ATR4.99
52-Week High112.43
Volume13,500,490
52-Week Low29.17
Most Recent Support Level76.28
Book Value1,596.9M
Most Recent Resistance Level80.48
P/B Ratio12.73
Upper Keltner92.90
P/S Ratio77.68
Lower Keltner70.43
Debt-to-Equity Ratio92.90
Next Earnings Date03/02/2026
Cash Surplus-28.2M
Next Ex-Dividend DateUnknown

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Revolution Medicines Inc In Our Stock Scanner

As of Jan 09, 2026
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Most Volatile StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.